阿斯利康(AstraZeneca)股价下跌,Datroway组合进入3期临床试验
· gurufocus.com
阿斯利康(AZN)这家肿瘤学和生物制药公司扩大了与Summit Therapeutics的癌症药物合作,其美国上市股票小幅下跌。
AstraZeneca AZN, the oncology and biopharmaceutical company, expanded its cancer-drug collaboration with Summit Therapeutics as U.S. shares edge a bit lower at ...